Tested Applications
| Positive WB detected in | TT cells, HeLa cells, mouse ovary tissue, mouse thymus tissue |
| Positive IHC detected in | human thyroid cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
14450-1-AP targets TSHR in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, zebrafish, sheep |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag5957 Product name: Recombinant human TSHR protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-253 aa of BC063613 Sequence: MRPADLLQLVLLLDLPRDLGGMGCSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLLPLGRKSLSFETQKAPRSSMPS Predict reactive species |
| Full Name | thyroid stimulating hormone receptor |
| Calculated Molecular Weight | 87 kDa |
| Observed Molecular Weight | 87 kDa, 62-70 kDa, 28-30 kDa |
| GenBank Accession Number | BC063613 |
| Gene Symbol | TSHR |
| Gene ID (NCBI) | 7253 |
| RRID | AB_2208263 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P16473 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Thyroid stimulating hormone (also known as thyrotropin or TSH) is a glycoprotein hormone produced by thyrotrophs in the anterior pituitary gland. The TSH receptor (TSHR), mainly expressed on the thyroid epithelial cells, is a G protein-coupled receptor (GPCR) of the seven-transmembrane domain family and plays a central role in controlling thyroid cell metabolism. The gene of TSHR maps to chromosome 14q31.1, and encodes a 764-amino acid protein with a predicted unmodified molecular weight of 86.8 kDa. The apparent molecular weight of glycosylated form is 95-120 kDa. Studies reveal that TSHR is composed of two subunits, A and B, which are produced by cleavage of single-chain TSHR on the cell surface and subsequently connected by disulfide bonds. This rabbit polyclonal antibody raised against N-terminal region (1-253 aa) of human TSHR can detect glycosylated subunit A with an experimentally determined molecular weight of 62-70 kDa under reducing condition. (PMID: 20578897, 17158770, 12593718)
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for TSHR antibody 14450-1-AP | Download protocol |
| WB protocol for TSHR antibody 14450-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TSHR Polyclonal antibody (Cat# 14450-1-AP) has 28 citations. These appear in journals including Theranostics, Cell Death & Disease, Cancer Letters, Journal of Hazardous Materials, Journal of Translational Medicine, BMC Medicine, International Journal of Nanomedicine, Oncotarget, Cancers, PLoS ONE, and others. Research fields span thyroid cancer (papillary, anaplastic, differentiated), Graves' disease and thyroid-associated ophthalmopathy, thyroid hormone synthesis, endocrine metabolism, environmental toxicology, and reproductive biology. Applications include WB, IF, and IHC.
| Species | Application | Title |
|---|---|---|
Theranostics Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer. | ||
Cell Death Dis PCSK9 promotes progression of anaplastic thyroid cancer through E-cadherin endocytosis | ||
Cancer Lett Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer | ||
J Hazard Mater Thyroid cancer risk associated with perfluoroalkyl carboxylate exposure: Assessment using a human dermal fibroblast-derived extracellular matrix-based thyroid cancer organoid | ||
J Transl Med Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves' disease. | ||
Int J Biol Macromol Bispecific aptamers target thyrotropin receptor (TSHR) and insulin growth factor-1 receptor (IGF-1R) for the improvement of orbital fibroblasts activation in the treatment of thyroid-associated ophthalmopathy |









